Martine Zimmermann, Vice President Global Regulatory Affairs, Alexion Pharmaceuticals joined us last year at the World Orphan Drug Congress Europe to present on ‘Ultra-rare skills for ultra-orphan success’
Download this presentation now to find out more about:
- What skills are required for overcoming the challenges in ultra-orphan drug development
- The importance of always keeping the focus on the end goal: the patient
- How together we can reach new heights in innovation for ultra-rare diseases
…And much more!
If you are interested in finding out more about ultra-orphan drug development, then join us at the 5th Annual World Orphan Drug Congress.